These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3435852)

  • 1. Properties and pharmacology of intravascular radiocontrast media.
    Morris TW
    Can J Cardiol; 1987 Nov; 3 Suppl A():6A-10A. PubMed ID: 3435852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and clinical introduction of low osmolality contrast media.
    Grainger RG
    Radiologe; 1981 Jun; 21(6):261-7. PubMed ID: 7268025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmolality of nonionic contrast media.
    Miklautz H; Fichte K; Wegscheider K
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():16-20. PubMed ID: 2568786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of intravascular radiocontrast media.
    Morris TW; Fischer HW
    Annu Rev Pharmacol Toxicol; 1986; 26():143-60. PubMed ID: 3521454
    [No Abstract]   [Full Text] [Related]  

  • 7. Safer contrast agents?
    Dawson P; Allison DJ
    Br J Hosp Med; 1989 Nov; 42(5):406-7. PubMed ID: 2597825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed vs. immediate adverse reactions to ionic and non-ionic low-osmolality contrast media.
    Oi H; Yamazaki H; Matsushita M
    Radiat Med; 1997; 15(1):23-7. PubMed ID: 9134581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-osmolality contrast media on red cell filterability.
    Imai H; Hiruma H; Kumazaki T; Uyesaka N
    Acta Radiol; 1993 May; 34(3):214-9. PubMed ID: 8489832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonionic low-osmolar contrast media have no impact on major adverse cardiac events in patients undergoing coronary stenting with appropriate antiplatelet therapy.
    Danzi GB; Capuano C; Sesana M; Predolini S; Baglini R
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):477-82. PubMed ID: 14624424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in contrast agents.
    Bettmann MA; Morris TW
    Radiol Clin North Am; 1986 Sep; 24(3):347-57. PubMed ID: 3529226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the acute cardiovascular side effects of iopamidol, metrizamide and amidotrizoate after intracoronary and left ventricular injections].
    Schräder R; Wolpers HG; Hoeft A; Korb H; Hellige G
    Radiologe; 1984 May; 24(5):240-6. PubMed ID: 6463236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low osmolar contrast media--a challenge for cardiology.
    Hobbs BB
    Can J Cardiol; 1987 Nov; 3 Suppl A():3A-5A. PubMed ID: 3435851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New non-ionic contrast: effects on the cardiovascular system.
    Pagny JY; Gaux JC
    Eur J Radiol; 1996 Nov; 23 Suppl 1():S2-5. PubMed ID: 9056156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective use of low osmolality contrast agents: cost and benefits.
    Ohnesorgen EG; Yoshino MT
    Radiol Technol; 1988; 59(6):499-502. PubMed ID: 3136507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages of the new low-osmolar radiographic contrast media.
    Bester L; Bagg M; Scher A
    S Afr Med J; 1986 Dec; 70(13):796-8. PubMed ID: 3798263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and old contrast agents: pharmacology, tissue opacification, and excretory urography.
    Spataro RF
    Urol Radiol; 1988; 10(1):2-5. PubMed ID: 3043872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-osmolality contrast media: premises and promises.
    McClennan BL
    Radiology; 1987 Jan; 162(1 Pt 1):1-8. PubMed ID: 3786748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-osmolality contrast media: a current perspective.
    King BF; Hartman GW; Williamson B; LeRoy AJ; Hattery RR
    Mayo Clin Proc; 1989 Aug; 64(8):976-85. PubMed ID: 2677533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.